Extent of clinical improvement after surgical treatment of hypertrophic obstructive cardiomyopathy

被引:161
|
作者
McCully, RB [1 ]
Nishimura, RA [1 ]
Tajik, AJ [1 ]
Schaff, HV [1 ]
Danielson, GK [1 ]
机构
[1] MAYO CLIN & MAYO FDN,DIV THORAC & CARDIOVASC SURG,ROCHESTER,MN 55905
关键词
cardiomyopathy; echocardiography; myectomy; mortality; surgery;
D O I
10.1161/01.CIR.94.3.467
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background A subgroup of patients with hypertrophic obstructive cardiomyopathy remain severely symptomatic despite optimal medical therapy. Septal myectomy reduces or eliminates left ventricular outflow obstruction and produces marked symptomatic improvement. With the recent advent of alternative methods for treatment of this disorder, such as dual-chamber pacing, it is necessary to establish the risks and benefits of septal myectomy in the modem surgical era. Methods and Results The clinical, EGG, echocardiographic, cardiac catheterization, and surgical data were analyzed for 65 patients 20 to 70 years old with hypertrophic obstructive cardiomyopathy who had surgical treatment between 1986 and 1992. Specific symptoms and overall functional status were evaluated before surgery and at the end of the first postoperative year. Subsequent long-term clinical postoperative follow-up was also obtained. The extent of postoperative improvement was measured by the presence and severity of persistent symptoms, overall New York Heart Association (NYHA) functional class, and patients' self-perceptions of overall improvement. Of the patients, 95% were in NYHA functional class LU or TV before surgery: 95% had dyspnea, 62% had angina, 63% had near-syncope, and 23% had syncope. The overall early mortality rate was 4.6%; there was no mortality among the 45 patients who underwent isolated septal myectomy. At the 1-year postoperative evaluation, 89% of survivors were in NYHA functional class I or II, and 47% believed that they had 100% improvement. Significant improvement (as defined) was seen in 67% of patients with dyspnea, 90% with angina, 86% with near-syncope, and 100% with syncope. The 5-year survival rate was 92%. Conclusions The results of the present study reaffirm the efficacy of surgical treatment of hypertrophic obstructive cardiomyopathy in patients who are severely symptomatic despite optimal medical therapy and serve as a useful reference by which the surgical approach can be compared with new and potentially promising treatment alternatives.
引用
收藏
页码:467 / 471
页数:5
相关论文
共 50 条
  • [1] CLINICAL AND ECHOCARDIOGRAPHIC OBSERVATIONS IN PATIENTS AFTER SURGICAL TREATMENT OF HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY
    KOHLER, E
    NEUHAUS, C
    THUROW, J
    BLUSCHKE, V
    KUHN, H
    KRELHAUS, W
    KORFER, R
    LOOGEN, F
    BIRCKS, W
    [J]. ZEITSCHRIFT FUR KARDIOLOGIE, 1978, 67 (12): : 826 - 836
  • [2] Surgical treatment for obstructive hypertrophic cardiomyopathy
    Kenji Minakata
    Ryuzo Sakata
    [J]. General Thoracic and Cardiovascular Surgery, 2014, 62 (3) : 184 - 185
  • [3] SURGICAL TREATMENT OF HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY
    ROTHLIN, M
    WIRZ, P
    PRETER, B
    GATTIKER, H
    SENNING, A
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1969, 94 (50) : 2579 - &
  • [4] Surgical treatment for obstructive hypertrophic cardiomyopathy
    Minakata, Kenji
    Sakata, Ryuzo
    [J]. GENERAL THORACIC AND CARDIOVASCULAR SURGERY, 2014, 62 (03) : 184 - 185
  • [5] Surgical treatment for hypertrophic obstructive cardiomyopathy
    Castedo, E
    Cabo, RA
    Núñez, L
    Monguló, E
    Montero, CG
    Burgos, R
    Serrano-Fiz, S
    Téllez, G
    González, M
    Cavero, MA
    Ugarte, J
    [J]. REVISTA ESPANOLA DE CARDIOLOGIA, 2004, 57 (08): : 751 - 756
  • [6] Surgical treatment of hypertrophic obstructive cardiomyopathy
    Schoendube, FA
    [J]. EUROPEAN HEART JOURNAL SUPPLEMENTS, 2001, 3 (0L) : L26 - L31
  • [7] SURGICAL TREATMENT OF HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY
    ROTHLIN, ME
    [J]. SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1977, 107 (09) : 289 - 292
  • [8] Clinical Outcomes After the Surgical Treatment of Hypertrophic Obstructive Cardiomyopathy With Left Ventricular Apical Aneurysm
    Tiemuerniyazi, Xieraili
    Chen, Liangcai
    Song, Yangwu
    Zhao, Wei
    Feng, Wei
    [J]. HEART LUNG AND CIRCULATION, 2023, 32 (09): : 1122 - 1127
  • [9] SURGICAL-TREATMENT OF HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY
    不详
    [J]. LANCET, 1989, 1 (8634): : 358 - 360
  • [10] SURGICAL-TREATMENT OF HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY
    MCKENNA, WJ
    GOODWIN, JF
    COUNIHAN, PJ
    PARKER, DJ
    PEPPER, JR
    WARD, DE
    [J]. LANCET, 1989, 1 (8636): : 507 - 507